Electropermeabilization of metastatic chondrosarcoma cells from primary cell culture.


Journal

Biotechnology and applied biochemistry
ISSN: 1470-8744
Titre abrégé: Biotechnol Appl Biochem
Pays: United States
ID NLM: 8609465

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 22 12 2018
accepted: 20 08 2019
pubmed: 3 9 2019
medline: 25 3 2020
entrez: 3 9 2019
Statut: ppublish

Résumé

Primary cell cultures are challenging, but reliable model reflecting tumor response in vitro. The study was designed to examine if the increased electropermeabilization can overcame initial drug insensitivity in chondrosarcoma cells from lung metastasis. We established a primary cell culture and evaluated the cytotoxic impact of four drugs-cisplatin (CDDP), camptothecin, 2-methoxyestradiol, and leucovorin calcium (LeuCa). After determination of parameters allowing for electropermeabilization, we performed electrochemotherapy in vitro with the least toxic drugs-CDDP and LeuCa. Although combining CDDP and leucovorin together increased their toxicity and supported apoptosis, application of pulsed electric fields (PEFs) brought no advantage for their efficacy. The study emphasizes the need for introduction of primary cell cultures into studies on pulse electric fields as model frequently less sensitive to PEF-based treatments than continuous cell lines.

Identifiants

pubmed: 31476023
doi: 10.1002/bab.1809
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

945-954

Informations de copyright

© 2019 International Union of Biochemistry and Molecular Biology, Inc.

Références

Taylor, M. W. (2014) Viruses and Man: A History of Interactions. pp. 41-52, Springer International Publishing, Cham.
Pan, C., Kumar, C., Bohl, S., Klingmueller, U., and Mann, M. (2009) Mol. Cell. Proteomics 8, 443-450.
Doyle, L. A., Yang, W., Abruzzo, L. V, Krogmann, T., Gao, Y., Rishi, A. K., and Ross, D. D. (1998) Proc. Natl. Acad. Sci. U.S.A. 95, 15665-70.
Kolesnikova, S. G., & Moiseeva, I. Y. (2017) Int. J. Phys. Conf. Ser. 784(1), p. 012028.
Alge, C. S., Hauck, S. M., Priglinger, S. G., Kampik, A., and Ueffing, M. (2006) J. Proteome Res. 5, 862-878.
Limaiem, F., and Sticco, K. L. (2019) Cancer, Chondrosarcoma. StatPearls [Internet].
Irigaray Canals, R. M., Extremera Fuentes, R., Romero Plaza, A., Mayol Mateu, A., and Blanquer Escribano, D. (2014) Arch. Bronconeumol. 51, 52.
Thomford, N. R., Woolner, L. B., and Clagett, O. T. (1965) J. Thorac. Cardiovasc. Surg. 49, 357-63.
Ehrenhaft, J. L., Lawrence, M. S., and Sensenig, D. M. (1958) Arch. Surg. 77, 606-612.
Nota, S. P. F. T., Braun, Y., Schwab, J. H., van Dijk, C. N., and Bramer, J. A. M. (2015) Sarcoma 2015, 1-11.
Italiano, A., Mir, O., Cioffi, A., Palmerini, E., Piperno-Neumann, S., Perrin, C., Chaigneau, L., Penel N., Duffaud F., Kurtz J. E., Collard O., Bertucci F., Bompas E., Le Cesne A., Maki R. G., Ray Coquard I., and Blay, J. Y. (2013) Ann. Oncol. 24, 2916-2922.
Terek, R. M., Schwartz, G. K., Devaney, K., Glantz, L., Mak, S., Healey, J. H., and Albino, A. P. (1998) J. Orthopaed. Res. 16, 585-590.
Lee, F. Y., Mankin, H. J., Fondren, G., Gebhardt, M. C., Springfield, D. S., Rosenberg, A. E., and Jennings, L. C. (1999) J. Bone Joint Surg. Am, 81, 326-338.
Mery, B., Espenel, S., Guy, J. B., Rancoule, C., Vallard, A., Aloy, M. T., Rodriguez-Lafrasse, C., and Magné, N. (2018) Crit. Rev. Oncol. Hematol. 126, 32-36.
Orlowski, S., and Mir, L. M. (1993) Biochim. Biophys. Acta 1154, 51-63.
Szewczyk, A., Gehl, J., Daczewska, M., Saczko, J., Frandsen, S. K., and Kulbacka, J. (2018) Oncotarget 9.
Pakhomov, A. G., Bowman, A. M., Ibey, B. L., Andre, F. M., Pakhomova, O. N., and Schoenbach, K. H. (2009) Biochem. Biophys. Res. Commun. 385, 181-186.
Kulbacka, J., Pucek, A., Kotulska, M., Dubińska-Magiera, M., Rossowska, J., Rols, M. P., and Wilk, K. A. (2016) Bioelectrochemistry 110, 19-31.
Kulbacka, J., Pucek, A., Wilk, K. A., Dubińska-Magiera, M., Rossowska, J., Kulbacki, M., and Kotulska, M. (2016) J. Membr. Biol. 249, 645-661.
Chu, G., Hayakawa, H., and Berg, P. (1987) Nucleic Acids Res., 15, 1311-1326.
André, F., and Mir, L. M. (2004). Gene Ther. 11(S1), S33.
Satkauskas, S., Bureau, M. F., Puc, M., Mahfoudi, A., Scherman, D., Miklavcic, D., and Mir, L. M. (2002) Mol. Ther. 5, 133-140.
Cadossi, R., Ronchetti, M., and Cadossi, M. (2014) Future Oncol. 10, 877-90.
Reinhold, U. (2011) Anticancer Drugs 2, 711-718.
Girelli, R., Prejanò, S., Cataldo, I., Corbo, V., Martini, L., Scarpa, A., Claudio, B. (2015) Radiol. Oncol. 49, 147-154.
Falk, H., Matthiessen, L. W., Wooler, G., and Gehl, J. (2018) Acta Oncol. (Madr.) 57, 311-319.
Serša, G., Štabuc, B., Čemažar, M., Miklavčič, D., and Rudolf, Z. (2000) Clin. Cancer Res. 6, 863-867.
Fini, M., Tschon, M., Ronchetti, M., Cavani, F., Bianchi, G., Mercuri, M., Alberghini, M., and Cadossi, R. (2010) J Bone Joint Surg. 92-B(11), 1614-1620.
Shimizu, T., Nikaido, T., Gomyo, H., Yoshimura, Y., Horiuchi, A., Isobe, K., Ebara, S., and Takaoka, K. (2003) J. Orthopaed. Sci. 8, 248-251.
de Bree, R., Tijink, B. M., van Groeningen, C. J., and Leemans, C. R. (2006) Sarcoma 2006, 1-5.
Cemazar, M., Sersa, G., and Miklavcic, D. (1998) Anticancer Res. 18, 4463-4466.
Cemazar, M., Miklavcic, D., Mir, L. M., Belchradek, J., Bonnay, M., Fourcault, D., and Sersa, G. (2001) Eur. J. Cancer 37,1166-1172.
Arena, C. B., Szot, C. S., Garcia, P. A., Rylander, M. N., and Davalos, R. V. (2012) Biophys. J. 103, 2033-2042.
Muratori, C., Pakhomov, A. G., Xiao, S., and Pakhomova, O. N. (2016) Sci. Rep. 6, 23225.
Gibot, L., Madi, M., Vézinet, R., and Rols, M. P. (2016). IFMBE Proc. 53, 200-203.
Shrivastav, S., Stone, K. R., Bonar, R. A., and Paulson, D. F. (1980) Cancer Res. 40, 4438-4442.
Saczko, J., Choromańska, A., Rembiałkowska, N., Dubińska-Magiera, M., Bednarz-Misa, I., Bar, J., and Kulbacka, J. (2015) Biomed. Pharmacother. 71, 30-36.
Taieb, J., Tabernero, J., Mini, E., Subtil, F., Folprecht, G., Van Laethem, J. L., Thaler, J., Bridgewater, J., Petersen, L. N., Blons, H., Collette, L., Van Cutsem, E., Rougier, P., Salazar, R., Bedenne, L., Emile, J. F., Laurent-Puig, P., Lepage, C., and PETACC-8 Study Investigators (2014) Lancet Oncol. 15, 862-873.
Erdem, G. U., Bozkaya, Y., Ozdemir, N. Y., Demirci, N. S., Yazici, O., and Zengin, N. (2018) Bosnian J. Basic Med. Sci. 18, 170-177.
Kulbacka, J., Daczewska, M. M., Dubińska-Magiera, M., Choromańska, A., Rembiałkowska, N., Surowiak, P. P., Kulbacki, M., Kotulska, M., and Saczko, J. (2014) Bioelectrochemistry 100, 96-104.
Liu, L. F., Desai, S. D., Li, T.-K., Mao, Y., Sun, M., and Sim, S.-P. (2006) Ann. N. Y. Acad. Sci. 922, 1-10.
Gallo, R. C. (1971) J. Natl. Cancer Inst. 46, 789-795.
Tamzali, Y., Borde, L., Rols, M. P., Golzio, M., Lyazrhi, F., and Teissie, J. (2012) Equine Vet. J. 44, 214-220.
Schreiber, R., Mezencev, R., Matyunina, L. V, and McDonald, J. F. (2016) Cancer Gene Ther. 23, 241-245.
Serša, G., Štabuc, B., Čemažar, M., Jančar, B., Miklavčič, D., and Rudolf, Z. (1998) Eur. J. Cancer 34, 1213-1218.
Spugnini, E. P., Renaud, S. M., Buglioni, S., Carocci, F., Dragonetti, E., Murace, R., Cardelli, P., Vincenzi, B., Baldi, A., and Citro, G. (2011) J. Transl. Med. 9(1), 152.
Lakhani, N. J., Sarkar, M. A., Venitz, J., and Figg, W. D. (2003) Pharmacotherapy 23, 165-72.
LaVallee, T. M., Zhan, X. H., Herbstritt, C. J., Kough, E. C., Green, S. J., and Pribluda, V. S. (2002) Cancer Res. 62, 3691-3697.
Moran, R. G. (1989) Cancer 63, 1008-1012.
Heymann, D., David, E., Blanchard, F., Heymann, M. F., De Pinieux, G., Gouin, F., and Rédini, F. (2011) Sarcoma. 2011, 932451
Michel, O., Kulbacka, J., Saczko, J., Mączyńska, J., Błasiak, P., Rossowska, J., and Rzechonek, A. (2018) Biomed. Res. Int. 2018, 1-12.
Michel, O., Przystupski, D., Saczko, J., Szewczyk, A., Niedzielska, N., Rossowska, J., and Kulbacka, J. (2018) Acta Biochim. Pol. 65, 173-184.
Ashby, J., Tinwell, H., Lefevre, P. A., and Browne, M. A. (1995) Mutagenesis 10, 85-90.
Van oosterwijk, J. G., Herpers, B., Meijer, D., Briaire-de bruijn, I. H., Cleton-jansen, A. M., Gelderblom, H., Van de water, B., Bée, J. V. M. G. (2012) Ann. Oncol. 23, 1617-1626.
Lechler, P., Renkawitz, T., Campean, V., Balakrishnan, S., Tingart, M., Grifka, J., and Schaumburger, J. (2011) BMC Cancer [Electronic Resource] 11, 120.
Wyman, J. J., Hornstein, A. M., Meitner, P. A., Mak, S., Verdier, P., Block, J. A., Pan, J., and Terek, R. M. (2000) J. Bone Joint Surg. 82, 22.
Bovée, J. V. M. G., Hogendoorn, P. C. W., Wunder, J. S., and Alman, B. A. (2010) Nat. Rev. Cancer 10, 481.
Romeo, S., Sannino, A., Scarfì, M. R., Vernier, P. T., Cadossi, R., Gehl, J., and Zeni, O. (2018) Technol. Cancer Res. Treat. 17.
Mir, L. M., Gehl, J., Sersa, G., Collins, C. G., Garbay, J. R., Billard, V., Geertsen, P. F., Rudolf, Z., O'Sullivan, G. C., Marty, M. (2006) Eur. J. Cancer 4, 14-25.
Sersa, G., Kranjc, S., Scancar, J., Krzan, M., and Cemazar, M. (2010) J. Membr. Biol. 236, 155-162.
Rols, M. P., and Teissié, J. (1998) Biophys. J. 75, 1415-1423.
Kotnik, T., Maček-Lebar, A., Miklavčič, D., and Mir, L. M. (2000) Biotechniques 28, 921-926.
Sözer, E. B., Pocetti, C. F., and Vernier, P. T. (2018) BMC Biophys. 11(1), 4.
Mir, L. M., Orlowski, S., Belehradek, J., Teissié, J., Rols, M. P., Serša, G., Miklavcic, D., Gilbert, R., and Heller, R. (1995) Bioelectrochem. Bioenergetics 38, 203-207.
Pucihar, G., Kotnik, T., Miklavčič, D., and Teissié, J. (2008) Biophys. J. 95, 2837-2848.
Jaroszeski, M. J., Dang, V., Pottinger, C., Hickey, J., Gilbert, R., and Heller, R. (2000) Anticancer Drugs 11, 201-208.
Bleyer, W. A. (1989) Cancer, 63, 995-1007.
Frandsen, S. K., Krüger, M. B., Mangalanathan, U. M., Tramm, T., Mahmood, F., Novak, I., and Gehl, J. (2017) Cancer Res. 77, 4389-4401.
Pakhomova, O. N., Gregory, B., Semenov, I., and Pakhomov, A. G. (2014) Biochim. Biophys. Acta 1838, 2547-2554.
Frandsen, S. K., Gissel, H., Hojman, P., Tramm, T., Eriksen, J., and Gehl, J. (2012) Cancer Res. 72, 1336-1341.
Zielichowska, A., Daczewska, M., Saczko, J., Michel, O., and Kulbacka, J. (2016) Bioelectrochemistry 109, 70-78.
Bertrand, R., Solary, E., O'Connor, P., Kohn, K. W., and Pommier, Y. (1994) Exp. Cell Res. 211, 314-321.

Auteurs

Olga Michel (O)

Department of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Poland.

Piotr Błasiak (P)

Department of Thoracic Surgery, Wroclaw Medical University, Wroclaw, Poland.

Jolanta Saczko (J)

Department of Molecular and Cellular Biology, Wroclaw Medical University, Wroclaw, Poland.

Julita Kulbacka (J)

Department of Molecular and Cellular Biology, Wroclaw Medical University, Wroclaw, Poland.

Małgorzata Drąg-Zalesińska (M)

Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, Wroclaw, Poland.

Adam Rzechonek (A)

Department of Thoracic Surgery, Wroclaw Medical University, Wroclaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH